Cargando…
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
Effectors from the immune system can modulate the course and possibly the early development of gliomas. We, therefore, hypothesized that autoimmune diseases associated with increased immune‐surveillance may also modulate the risk of human glioma. To test this hypothesis, we used data from the well‐v...
Autores principales: | Anssar, Tareq M., Leitzmann, Michael F., Linker, Ralf A., Meier, Christoph, Becker, Claudia, Jick, Susan, Sahm, Katharina, Platten, Michael, Hau, Peter, Seliger, Corinna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997055/ https://www.ncbi.nlm.nih.gov/pubmed/31821741 http://dx.doi.org/10.1002/cam4.2767 |
Ejemplares similares
-
Antimicrobial drug use and the risk of glioma: A case–control study
por: Haedenkamp, Tareq M., et al.
Publicado: (2022) -
Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
por: Seliger, Corinna, et al.
Publicado: (2016) -
Metabolic syndrome in relation to risk of meningioma
por: Seliger, Corinna, et al.
Publicado: (2016) -
Diabetes, use of metformin, and the risk of meningioma
por: Seliger, Corinna, et al.
Publicado: (2017) -
History of chickenpox in glioma risk: a report from the glioma international case–control study (GICC)
por: Amirian, E. Susan, et al.
Publicado: (2016)